December 27, 2016
Following the commercial success of its Rhodimet® AT88, Adisseo is developing production capacity in Europe
After completion of the fully integrated Nanjing plant late 2015, Adisseo is now the market leader in liquid methionine. For several years, the company has been promoting liquid methionine (HMTBA) amongst feed-millers and integrators all over the world.
The next step in Adisseo development is a significant extension of the Burgos (Spain) facility in order to expand production of liquid methionine according to the needs of Adisseo customers. The success of Rhodimet® AT88 in recent years (+50% since 2013) has fostered the need to accelerate the capacity extension project in Spain.
Adding a third production line in Burgos will increase the site competitiveness in many aspects, making it one of the best of its kind in the industry. Adisseo is also implementing an investment programme to upgrade its upstream facility of Les Roches, France, in order to sustain the development of the Burgos site.
With this programme, Adisseo is reinforcing its industrial strategy combining Chinese and European expertise and to develop the full potential of its existing facilities in order to support the growth of its customers and to meet their request for a high quality, cost efficient source of methionine.
Adisseo wishes to express its gratitude to all its customers worldwide who have selected its Rhodimet® AT88 product, allowing significant market growth in recent years and demonstrating its full value to its users.